Amna Siddiqui

Dr. Amna Siddiqui

Karachi Medical and Dental College, Karachi, Sindh, Pakistan
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2023 in Health Science Reports
Verified
Journal Article
Open access
MEMohammad Yasir Essar
Mohammad Yasir Essar
ASAmna Siddiqui
Amna Siddiqui
MHMichael Head
Michael Head
Background and Aim: Afghanistan is grappling with a severe health crisis marked by a high prevalence of infectious diseases, particularly tuberculosis, malaria, HIV, and the added strain of the COVID‐19 pandemic. The nation's healthcare system, already fragile, faces formidable challenges. Socioeconomic constraints, including limited resources and financial barriers, hinder healthcare accessibility, leading to delayed or inadequate care. Environmental factors, such as poor sanitation and crowded living conditions, exacerbate the transmission of diseases, especially waterborne illnesses. Governance issues, encompassing transparency, corruption, and political instability, disrupt healthcare efficiency and resource allocation. Addressing these multifaceted issues is vital to enhance Afghanistan's healthcare system and overall well‐being. The withdrawal of international support has exacerbated these challenges. The primary research goal is to deeply understand Afghanistan's health system, focusing on the major disease burdens: Tuberculosis, Malaria, AIDS, COVID‐19, Measles, Hepatitis, and Cholera. The study aims to assess the feasibility and effectiveness of current approaches, presenting a comprehensive view of challenges and opportunities within the Afghan healthcare system. The research concludes by highlighting policy implications, practical implementation, and offering recommendations for future endeavors.Methodology: This paper provides a thorough analysis of the literature concerning infectious diseases in Afghanistan and the enhancement of the healthcare system in the nation. A systematic exploration of the literature was conducted through PubMed and Google Scholar databases. The search terms used encompassed “Tuberculosis” OR “TB,” “Malaria,” “acquired immunodeficiency syndrome” OR “AIDS,” “Human immunodeficiency virus” OR “HIV,” “COVID‐19,” “Measles,” “Hepatitis virus,” “Cholera,” “Health system improvement,” and “Afghanistan.” Additionally, external sources like UNICEF, CDC, and WHO were referenced.Results: In conclusion, while improving access to vital medicines and vaccines is crucial for enhancing health outcomes in Afghanistan, significant challenges must be addressed to ensure the effectiveness and sustainability of such strategies. The Afghan health system's fragile governance, corruption, logistical complexities, and failure to address broader social and economic factors pose significant risks and obstacles to the implementation of proposed health strategies. Therefore, the strategies discussed in this analysis align with key Sustainable Development Goals, particularly SDG 3, and their successful implementation will have implications not only for the health and well‐being of Afghanistan but also for global health.Conclusion: Hence, by adopting a comprehensive approach with complementary interventions as discussed, we can address issues in the Afghan health system and reduce transmissible diseases’ burden, thereby building a better world for all.

5 August 2024 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
MKMuhammad Taha Khan
Muhammad Taha Khan
AKAyesha Rahman Khan
Ayesha Rahman Khan
SRSamia Rohail
Samia Rohail
FRFatima Ali Raza
Fatima Ali Raza
SAShahzaib Ahmed
Shahzaib Ahmed
AGAman Goyal
Aman Goyal

22 June 2023 in Health Science Reports
Verified
Journal Article
Open access
AJAreesha Jawed
Areesha Jawed
ZTZoaib Habib Tharwani
Zoaib Habib Tharwani
ASAmna Siddiqui
Amna Siddiqui
WMWaniyah Masood
Waniyah Masood
KQKhulud Qamar
Khulud Qamar
MHMichael G. Head
Michael G. Head
Background and Aims: South Asian countries, including Pakistan, Afghanistan, India, and Bangladesh, have a high prevalence of pulmonary and extra‐pulmonary tuberculosis (EPTB). This prevalence is influenced by various risk factors such as ethnicity, nutrition, socioeconomic disparities, high out‐of‐pocket healthcare expenses, and specific Mycobacterium Tuberculosis (TB) lineages. The COVID‐19 pandemic has likely hindered access to healthcare and led to under‐reporting of EPTB cases nationally and internationally. This rapid review aimed to summarize the literature on the prevalence and disease outcomes of EPTB in the mentioned countries, compare the situations across countries, and provide recommendations for future action.Methods: The review utilized PubMed and Google Scholar databases to search for literature on EPTB in South Asian countries. The search string included keywords related to different forms of EPTB and the countries of interest while excluding pulmonary tuberculosis.Results: The results showed that both TB, including drug‐resistant TB, and EPTB are prevalent and burdensome in South Asia. In Pakistan, pleural TB was the most commonly reported form of EPTB, followed by lymph node TB, abdominal TB, osteoarticular TB, Central Nervous System TB, and miliary TB. In India, lymph node TB(LNTB) was more common among EPTB cases. Bangladesh reported a high prevalence of EPTB involving lymph node, pleura, and abdomen, while Afghanistan had a higher prevalence of forms such as LNTB and tuberculous meningitis.Conclusion: In conclusion, the prevalence of EPTB in Pakistan, Afghanistan, India, and Bangladesh is alarmingly high and negatively impacts population health. Effective measures are needed for treatment and management of this condition, along with addressing current and future challenges. Strengthening the evidence base through surveillance and research is crucial to understand the patterns and significant factors related to EPTB, requiring investment in these areas.

23 February 2022 in Health Science Reports
Verified
Journal Article
Open access
ASAmna Siddiqui
Amna Siddiqui
AAAlishba Adnan
Alishba Adnan
MAMunib Abbas
Munib Abbas
STShafaq Taseen
Shafaq Taseen
SOSidhant Ochani
Sidhant Ochani
MEMohammad Yasir Essar
Mohammad Yasir Essar
Background: The heterologous prime‐boost vaccination technique is not novel as it has a history of deployment in previous outbreaks.Aim: Hence, this narrative review aims to provide critical insight for reviving the heterologous prime‐boost immunization strategy for SARS‐CoV‐2 vaccination relative to a brief positive outlook on the mix‐dose approach deployed in previous and existing outbreaks (ie, Ebola virus disease (EVD), malaria, tuberculosis, hepatitis B, HIV and influenza virus).Methodology and Materials: A Boolean search was carried out to find the literature in MEDLINE‐PubMed, Clinicaltrials, and Cochrane Central Register of Controlled Trials databases up till December 22, 2021, using the specific keywords that include “SARS‐CoV2”, “COVID‐19”, “Ebola,” “Malaria,” “Tuberculosis,” “Human Immunodeficiency Virus,” “Hepatitis B,” “Influenza,” “Mix and match,” “Heterologous prime‐boost,” with interposition of “OR” and “AND.” Full text of all the related articles in English language with supplementary appendix was retrieved. In addition, the full text of relevant cross‐references was also retrieved.Results: Therefore, as generally evident by the primary outcomes, that is, safety, reactogenicity, and immunogenicity reported and updated by preclinical and clinical studies for addressing previous and existing outbreaks so far, including COVID‐19, it is understood that heterologous prime‐boost immunization has been proven successful for eliciting a more efficacious immune response as of yet in comparison to the traditional homologous prime‐boost immunization regimen.Discussion: Accordingly, with increasing cases of COVID‐19, many countries such as Germany, Pakistan, Canada, Thailand, and the United Kingdom have started administering the heterologous vaccination as the technique aids to rationalize the usage of the available vaccines to aid in the global race to vaccinate majority to curb the spread of COVID‐19 efficiently. However, the article emphasizes the need for more large controlled trials considering demographic details of vaccine recipients, which would play an essential role in clearing the mistrust about safety concerns to pace up the acceptance of the technique across the globe.Conclusion: Consequently, by combatting the back‐to‐back waves of COVID‐19 and other challenging variants of concerns, including Omicron, the discussed approach can also help in addressing the expected evolution of priority outbreaks as coined by WHO, that is, “Disease X” in 2018 with competency, which according to WHO can turn into the “next pandemic” or the “next public health emergency,” thus would eventually lead to eradicating the risk of “population crisis.”

11 September 2022 in Health Science Reports
Verified
Journal Article
Open access
SAShkaib Ahmad
Shkaib Ahmad
UAUnaiza Ahmad
Unaiza Ahmad
HCHuzaifa Ahmad Cheema
Huzaifa Ahmad Cheema
NINida Iqbal
Nida Iqbal
ASAbia Shahid
Abia Shahid
ZAZain Ul Abadeen
Zain Ul Abadeen
Background: Pakistan being a low‐ and middle‐income country, its institutes are substantially deficient in scientific and technological aspects and share limited research contributions to the world repositories. Therefore, there is a rising concern to reflect on the history and status of publishing attitudes among medical students in Pakistan and to highlight and address the barriers that they are facing.Methods: A study was conducted aiming to determine the experience, motivation, and attitude of medical students in regarding publishing practices throughout Pakistan in several medical colleges. A multivariable logistic regression model was used to find the independent predictors of students publishing a research article. Forward selection was used to arrive at the final stepwise logistic regression. Odds ratio (OR) and 95% confidence interval (CI) were calculated. p < 0.05 was considered significant for all statistical tests.Results: From a sample size of 1225 participants, only 6.6% of students had published an article in our study. Of these, 59% were males and 31.3% were in final year. Males were more likely to publish articles than females (OR = 2.69, 95% CI: 1.37–5.26) and final‐year students were more likely to publish articles than first‐year students (OR = 7.48, 95% CI: 1.34–41.81). Students that had the knowledge that performing research is the way through which they will be judged for jobs had significantly higher odds of getting an article published (OR = 16.21, 95% CI: 3.65–71.88). Additionally, students who had been taught how to write a paper and those who knew the process of submitting an article were more likely to get published than the others.Conclusion: Our study has successfully highlighted the status of publishing among medical students in Pakistan. Our findings serve as an eye opener and call to action for authorities to address the grievances of students in terms of barriers, lack of mentorship, and lack of research teaching. We hope our findings can guide a strong policy change to facilitate the next generation of passionate researchers.

4 April 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SOSidhant Ochani
Sidhant Ochani
ASAmna Siddiqui
Amna Siddiqui
AAAlishba Adnan
Alishba Adnan
Levothyroxine, also known as L-thyroxine, is a manufactured form of the thyroid hormone thyroxine which is considered to be a gold-standard therapy for treating an underactive thyroid gland (hypothyroidism). Some experts highlight benefits of LT4 replacement therapy, others specify the harmful effects of it, in regards to treating subclinical hypothyroidism. With respect to current guidelines for the consistent dosing of levothyroxine for treating hypothyroidism, we aim to highlight limitations of long-term use of Levothyroxine therapy in SCH. Apropos of the studies published to date, we look into the appropriate dosing of Levothyroxine in SCH by physicians.